Safe Pharma

Short Summary

Safe Pharma is going to design the most accurate packages for gastric cancer, depression, and cardiovascular problems treatments using specific crocin type which will be biosynthesised according to exclusive active sites of involved genes.


Investment Raised
Previous Rounds N/A
Stage Pre-Startup/R&D
Investor Role


  • We have the most accurate treatment package for gastric cancer patients
  • Extremely large target markets based on our products/services
  • Producing drugs to cure important health problems without side effects
Please note: The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Investors should carry out their own due diligence and take professional advice where necessary.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

28% raised

New Diagnostic Technology

location_on East Midlands, United Kingdom

For decades, inaccuracies in pregnancy testing have become commonplace, even though many manufacturers claim over 99% accuracy. Our patented, scientifically proven technology can eradicate this problem and will generate high returns for investors

£ 700,000


£ 40,000

Min per Investor

Global Pro
5% raised

Marketplace in Healthcare

location_on North West, United Kingdom

Marketplace in Healthcare. Connecting buyers and sellers where health data is required for risk management. FDA & CE cleared features. $250,000 in Pre Orders. COO & CFO with 30+ yrs experience. Previously raised £116k. Powered by AI. Launch Ready.

£ 350,000


£ 500

Min per Investor

0% raised

V**** Q*****

location_on London, United Kingdom

VQ is a wearable fitness tracker dedicated to personalised wellness through accurate, user-friendly technology. Track multiple metrics, reveal health status and trajectory, discover personalised advice based on results.

£ 70,000


£ 1,000

Min per Investor

load one similar proposal